Skip to main navigation Skip to search Skip to main content

Methods for analytical validation of novel digital clinical measures: A simulation study

  • Simon Turner*
  • , Chen Chen
  • , Rolando Acosta
  • , Rachell Chon
  • , Eric J. Daza
  • , Lysbeth Floden
  • , Joss Langford
  • , Leif Simmatis
  • , Berend Terluin
  • , Benjamin Vandendriessche*
  • , Piper Fromy
  • *Corresponding author for this work
  • Digital Medicine Society
  • Alphabet Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Rocky Vista University
  • Stats-of-1
  • Evinova
  • Activinsights Ltd.
  • University of Exeter
  • University of Toronto
  • Vrije Universiteit Amsterdam
  • Amsterdam UMC
  • Case Western Reserve University

Research output: Contribution to journalArticleAcademicpeer-review

4 Downloads (Pure)

Abstract

Analytical validation is a crucial step in the evaluation of algorithms that process data from sensor-based digital health technologies (sDHTs). Analytical validation of novel digital measures can be complicated when reference measures with directly comparable units are not available. To address this, we conducted a simulation study. Data was simulated assuming a latent physical ability trait, indirectly accessed through an sDHT-derived target measure collecting step count data, and the items of a clinical outcome assessment (COA) measuring self-reported physical activity. We quantified the ability of two methods to assess the latent relationship between reference and target measures: the Pearson Correlation Coefficient (PCC) and factor correlations from a two-factor confirmatory factor analysis (CFA) model. Additionally, three multiple linear regression models were used to evaluate if multiple COA reference measures can more completely represent a target measure of interest. Our findings show that PCC was more stable, easier to compute, and relatively robust with respect to violations of parametric assumptions than CFA, particularly with small sample sizes. However, CFA was less biased than PCC in all scenarios investigated. We demonstrate that using both PCC and CFA generates more confidence in the results of a target and reference measure comparison. Finally, regression results suggest that incorporating multiple reference measures with more frequent collection time points can provide a more complete presentation of the sDHT’s analytical validity. Novel digital measures are being developed at an accelerating pace and promise to revolutionize patient care and medical product development. Our findings provide investigators with crucial information for choosing appropriate methods to perform rigorous analytical validation of these novel measures, including an open-access simulation toolkit.
Original languageEnglish
Article numbere0308190
JournalPLoS ONE
Volume21
Issue number5 May
DOIs
Publication statusPublished - 1 May 2026

Fingerprint

Dive into the research topics of 'Methods for analytical validation of novel digital clinical measures: A simulation study'. Together they form a unique fingerprint.

Cite this